Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review

被引:31
作者
Xiao, Ye-Lei [1 ]
Wang, Kang [1 ]
Liu, Qiang [2 ]
Li, Jie [1 ]
Zhang, Xiang [1 ]
Li, Hong-Yuan [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing 400016, Peoples R China
[2] Peoples Hosp Dazu Dist, Dept Gen Surg, Chongqing, Peoples R China
关键词
BRCA gene mutation; Breast cancer risk/recurrence; Risk-reducing salpingo-oophorectomy; BRCA2 MUTATION CARRIERS; PROPHYLACTIC OOPHORECTOMY; TUMOR CHARACTERISTICS; PROGNOSTIC-FACTORS; THERAPY; PENETRANCE; STATISTICS; MASTECTOMY; WOMEN; AGE;
D O I
10.1016/j.clbc.2018.09.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We performed a meta-analysis to examine the relationship between risk-reducing salpingo-oophorectomy (RRSO) and breast cancer (BC) risk and mortality. RRSO was associated with a significant reduction in the incidence of BC in women with BRCA1/2 mutations, regardless of history of BC. RRSO could improve the survival of women with BC. Background: Objections have been raised to performing risk-reducing salpingo-oophorectomy (RRSO) to reduce disease incidence and mortality of women with BRCA mutations. We aimed to examine the relationship between RRSO and breast cancer (BC) risk and mortality with a meta-analysis. Materials and Methods: We conducted a comprehensive literature search using the PubMed and Embase databases for literature published from these databases' creation to September 2017. Hazard ratio (HR) estimates were identified directly from the original articles. Pooled results were calculated on the basis of nonoverlapping studies by fixed-effect meta-analysis. Results: RRSO was associated with a significant reduction in the incidence of BC in women with BRCA1/2 mutations who had no history of BC (HR = 0.58; 95% confidence interval [CI], 0.37 to 0.78). Even in women with a history of BC, RRSO could reduce the risk of recurrence (HR = 0.50; 95% CI, 0.31 to 0.69). We further found that publication year was a critical interaction factor from a corresponding subgroup analyses in BC risk (P-heterogeneity = .024). In addition, we found that RRSO could improve the survival of women with BC (HR = 0.33; 95% CI, 0.28 to 0.38). Conclusion: Summary estimates presented here indicate that RRSO was closely related to the reduced risk of BC caused by BRCA mutations, but publication year was a critical interaction factor and it should be noted that more recent studies have failed to find a significant reduction in BC risk associated with RRSO. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E48 / E65
页数:18
相关论文
共 35 条
[1]  
[Anonymous], J MINIMAL INVASIVE G
[2]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[3]   Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases [J].
Brekelmans, C. T. M. ;
Tilanus-Linthorst, M. M. A. ;
Seynaeve, C. ;
Van der Ouweland, A. ;
Menke-Pluymers, M. B. E. ;
Bartels, C. C. M. ;
Kriege, M. ;
van Geel, A. N. ;
Burger, C. W. ;
Eggermont, A. M. M. ;
Meijers-Heijboer, H. ;
Klijn, J. G. M. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (05) :867-876
[4]   Survival and prognostic factors in BRCA1-associated breast cancer [J].
Brekelmans, CTM ;
Seynaeve, C ;
Menke-Pluymers, M ;
Brüggenwirth, HT ;
Tilanus-Linthorst, MMA ;
Bartels, CCM ;
Kriege, M ;
van Geel, AN ;
Crepin, CMG ;
Blom, JC ;
Meijers-Heijboer, H ;
Klijn, JGM .
ANNALS OF ONCOLOGY, 2006, 17 (03) :391-400
[5]   Age at menarche and menopause and breast cancer risk in the international BRCA1/2 Carrier Cohort Study [J].
Chang-Claude, Jenny ;
Andrieu, Nadine ;
Rookus, Matti ;
Brohet, Richard ;
Antoniou, Antonis C. ;
Peock, Susan ;
Davidson, Rosemarie ;
Izatt, Louise ;
Cole, Trevor ;
Nogues, Catherine ;
Luporsi, Elisabeth ;
Huiart, Laetitia ;
Hoogerbrugge, Nicoline ;
Van Leeuwen, Flora E. ;
Osorio, Ana ;
Eyfjord, Jorunn ;
Radice, Paolo ;
Goldgar, David E. ;
Easton, Douglas F. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (04) :740-746
[6]   Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: Results from INT 0101 (E5188) [J].
Davidson, NE ;
O'Neill, AM ;
Vukov, AM ;
Osborne, CK ;
Martino, S ;
White, DR ;
Abeloff, MD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5973-5982
[7]   Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study [J].
Eisen, A ;
Lubinski, J ;
Klijn, J ;
Moller, P ;
Lynch, HT ;
Offit, K ;
Weber, B ;
Rebbeck, T ;
Neuhausen, SL ;
Ghadirian, P ;
Foulkes, WD ;
Gershoni-Baruch, R ;
Friedman, E ;
Rennert, G ;
Wagner, T ;
Isaacs, C ;
Kim-Sing, C ;
Ainsworth, P ;
Sun, P ;
Narod, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7491-7496
[8]   Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer [J].
Evans, D. Gareth R. ;
Ingham, Sarah L. ;
Baildam, Andrew ;
Ross, Gary L. ;
Lalloo, Fiona ;
Buchan, Iain ;
Howell, Anthony .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) :135-142
[9]   Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation [J].
Finch, Amy P. M. ;
Lubinski, Jan ;
Moller, Pal ;
Singer, Christian F. ;
Karlan, Beth ;
Senter, Leigha ;
Rosen, Barry ;
Maehle, Lovise ;
Ghadirian, Parviz ;
Cybulski, Cezary ;
Huzarski, Tomasz ;
Eisen, Andrea ;
Foulkes, William D. ;
Kim-Sing, Charmaine ;
Ainsworth, Peter ;
Tung, Nadine ;
Lynch, Henry T. ;
Neuhausen, Susan ;
Metcalfe, Kelly A. ;
Thompson, Islay ;
Murphy, Joan ;
Sun, Ping ;
Narod, Steven A. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) :1547-U43
[10]   Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers [J].
Finkelman, Brian S. ;
Rubinstein, Wendy S. ;
Friedman, Sue ;
Friebel, Tara M. ;
Dubitsky, Shera ;
Schonberger, Niecee Singer ;
Shoretz, Rochelle ;
Singer, Christian F. ;
Blum, Joanne L. ;
Tung, Nadine ;
Olopade, Olufunmilayo I. ;
Weitzel, Jeffrey N. ;
Lynch, Henry T. ;
Snyder, Carrie ;
Garber, Judy E. ;
Schildkraut, Joellen ;
Daly, Mary B. ;
Isaacs, Claudine ;
Pichert, Gabrielle ;
Neuhausen, Susan L. ;
Couch, Fergus J. ;
van't Veer, Laura ;
Eeles, Rosalind ;
Bancroft, Elizabeth ;
Evans, D. Gareth ;
Ganz, Patricia A. ;
Tomlinson, Gail E. ;
Narod, Steven A. ;
Matloff, Ellen ;
Domchek, Susan ;
Rebbeck, Timothy R. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :1321-1328